2018
DOI: 10.14309/00000434-201810001-00417
|View full text |Cite
|
Sign up to set email alerts
|

Avoidant/Restrictive Food Intake Disorder in the Adult Gastroenterology Population: An Under-Recognized Diagnosis?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
19
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 16 publications
(21 citation statements)
references
References 0 publications
2
19
0
Order By: Relevance
“…We found 52 patients (21.8%) met criteria for other FEDs driven by body shape/weight concerns (by n = 239 who completed the EDDS). This frequency is similar to other studies showing 23%‐28% eating disorder presence by self‐report among patients presenting for dysmotility evaluation or disorders of gut‐brain interaction 23‐25 . Dietary restriction, including fasting, to control body/shape weight is important to screen for, as twenty‐eight participants met criteria for eating disorders and endorsed restricting their diet, 5 of whom met criteria for anorexia nervosa.…”
Section: Discussionsupporting
confidence: 84%
See 4 more Smart Citations
“…We found 52 patients (21.8%) met criteria for other FEDs driven by body shape/weight concerns (by n = 239 who completed the EDDS). This frequency is similar to other studies showing 23%‐28% eating disorder presence by self‐report among patients presenting for dysmotility evaluation or disorders of gut‐brain interaction 23‐25 . Dietary restriction, including fasting, to control body/shape weight is important to screen for, as twenty‐eight participants met criteria for eating disorders and endorsed restricting their diet, 5 of whom met criteria for anorexia nervosa.…”
Section: Discussionsupporting
confidence: 84%
“…Recently in the gastroenterology field, there has been increased interest in the overlap of ARFID with disorders of gut‐brain interaction (formerly called functional gastrointestinal disorders) 16 . ARFID symptoms have been reported between 19.6% and 23.7% among patients overall in neurogastroenterology and motility settings, 24,25,39 one of which used the same NIAS self‐report scale as in this study 24 . Importantly, the frequency of ARFID symptoms in the present sample was much higher (40%).…”
Section: Discussionmentioning
confidence: 92%
See 3 more Smart Citations